The detection of inhaled anesthetics, such as dinitrogen monoxide, via standard drug screening methodologies is generally not performed. Standard panels focus on substances with higher abuse potential and longer detection windows. Routine workplace or legal drug tests are not designed to identify the presence of this particular gas.
The absence of testing for this substance stems from several factors. Its rapid elimination from the body means the detection window is extremely narrow. The substance dissipates quickly after exposure, rendering its presence undetectable within a short timeframe. Moreover, due to its primary use in medical and dental settings, as well as culinary applications, broad-scale screening is not considered practical or cost-effective.